Centene reports FY 2025 GAAP loss of $13.53 per share; guides FY 2026 adj. EPS >$3.00

CENTENE CORP

2025-FY EPS reported -$13.53 revenue$194,777,000,000

Full-year GAAP diluted loss per share $(13.53) includes $6.7B goodwill impairment; adjusted diluted EPS $2.08.
Q4 premium and service revenues $44.7B (+23% YoY); HBR 94.3% vs 89.6% due to Marketplace morbidity and PDP program changes.
Medicaid membership fell to 12.5M from 13.0M; Marketplace membership rose to 5.5M from 4.4M.
Signed definitive agreement to divest remaining Magellan Health businesses; recorded $513M impairment.
2026 guidance: adjusted diluted EPS >$3.00, with expected margin improvement and EPS growth.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.